The Greek company Genepharm has been acquired by MS Pharma during the 1st semester of 2019, where Genepharm, that is based in Athens and founded in 1967, works on the development, manufacturing, marketing and out-licensing of high-value generic pharmaceutical products in different countries. The company retains an extensive network of over 223 customers across 70 countries worldwide and has around 300 employees working there.
Genepharm covers several therapeutic areas with a special focus on:
- Oncology – oral and Injectable forms
- Central Nervous System
- Cardiovascular and Diabetes